framycetin has been researched along with Acute Disease in 79 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 60 (75.95) | 18.7374 |
| 1990's | 5 (6.33) | 18.2507 |
| 2000's | 9 (11.39) | 29.6817 |
| 2010's | 3 (3.80) | 24.3611 |
| 2020's | 2 (2.53) | 2.80 |
| Authors | Studies |
|---|---|
| Dat, AD; Doust, J; Pham, KB; Poon, F | 1 |
| Catovsky, D; Darrell, J; Donnelly, P; Galton, DA; Goldman, JM; Johnson, SA; Starke, ID | 1 |
| Dada, T; Dada, VK; Sharma, N; Vajpayee, RB | 1 |
| Jameson, B; McElwain, TJ; Storring, RA; Wiltshaw, E | 1 |
| Jameson, B; Watson, JG | 1 |
| Dirdal, M | 1 |
| Keating, MJ; Penington, DG | 1 |
| Babin, MB; Beylot, C | 1 |
| Ahmed, E; Roy, IS; Roy, SN | 1 |
| Jiao, J; Li, Q; Liu, J; Luo, F; Pan, C; Qi, B; Shang, D; Yin, P; Zhang, G; Zhang, Q; Zhao, L | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Drehobl, M; Goldstein, G; Guerrero, JL; Lacarte, PR; Luber, S; Mata, FS | 1 |
| Dohar, JE; McLean, C; Roland, P; Stroman, DW; Wall, GM | 1 |
| Adhikari, P; Bhandari, S; Bhatta, R; Pyakurel Bhatta, M | 1 |
| Baugh, RF; Schaefer, P | 1 |
| Baliasinskaia, GL | 1 |
| NIELSEN, JC | 1 |
| STAUDACHER, M | 1 |
| Appenroth, E; Gstöttner, M; Nagl, M; Neher, A; Reisigl, F; Schindler, M; Stephan, K; Ulmer, H; Wischatta, M | 1 |
| Flook, EP; Johnston, MN; Mehta, D; Mortimore, S | 1 |
| Chawla, O; Masood, A; Moumoulidis, I; Panesar, J; Ray, S | 1 |
| Bayon, R; Goyal, S; Hotaling, J; Izzo, AD; Otting, M; Richter, CP; Suh, E; Walsh, JT | 1 |
| Jameson, B; Judson, I; Kay, HE; Lawson, DN; Lumley, H; McElwain, TJ; Morgenstern, GR; Powles, RL; Watson, JG | 1 |
| Anderson, RU | 1 |
| Doraisingham, S; Goh, KT; Yin-Murphy, M | 1 |
| Brunner, G | 1 |
| Belvisi, A; Camarri, E; Frigerio, G; Guidoni, G; Marini, G | 1 |
| Berchtold, M; Müller, R | 1 |
| Berthier, JM; Dehesa, M; García-Ramos, G; Lewis, H; Mata, JM; Ramírez Acosta, J; Sierra, JG; Uribe, M | 1 |
| Doffoël, M; Vetter, D | 1 |
| Allaz, JL; Blanc, P; Buttigieg, R; Daurès, JP; Desprez, D; Larrey, D; Liautard, J; Michel, H; Pageaux, G; Parelon, G | 1 |
| Alexander, JW; Gennari, R; Gianotti, L; Munda, R; Pyles, R | 1 |
| Carpenedo, R; Mannaioni, G; Moroni, F | 1 |
| Agüero, J; Calvo, J; de las Heras, G; Fernández Fernández, F; Forcelledo, JL; Gutiérrez, JM; Mayorga, M; Obaya, S; Pons Romero, F | 1 |
| Chamuleau, RA | 1 |
| Jmelnitzky, AC | 1 |
| Lomtadze, ZD | 1 |
| Lorenzelli, A; Milazzo, F; Resta, M; Vigevani, GM; Vitali, D | 1 |
| Caruso, D; De Martino, G; Gatti, A; Iardino, V | 1 |
| Ershov, IuA; Gubskiĭ, LV | 1 |
| André, JM | 1 |
| Cunningham, MJ; Harley, EH | 1 |
| de Vries-Hospers, H; Dekker, A; Gaus, W; Kurrle, E; van der Waaij, D; Wendt, F | 1 |
| Dekker, A; Rozenberg-Arska, M; Verhoef, J | 1 |
| Gilbert, GJ | 1 |
| Bradley, JM; Jeffries, DJ; Mummery, RV | 1 |
| Nedoseko, GF; Russkiĭ, LI; Vladimirov, VV | 1 |
| Fischer, JE | 1 |
| Reichel, F; Sevcik, B; Sevciková, E; Straková, J | 1 |
| Ambrosiani, S; Spada, A | 1 |
| Ditunno, JF; Naso, F | 1 |
| Heinemann, M | 1 |
| Fox, SL | 1 |
| Goldstein, IM; Henderson, ES; Preisler, HD | 1 |
| Abkarovich, GF | 1 |
| Garrett, JA; Gray, JG; Lees, W; Longland, CJ | 1 |
| Vereshchagin, IA | 2 |
| Unich, NK | 1 |
| Gastpar, H | 1 |
| Candlin, FT | 1 |
| Astapov, AA; Tsynkalovskii, IB | 1 |
| Bell, B; Jacobson, S | 1 |
| Everett, MT | 1 |
| Barnes, GL; Bishop, RF; Townley, RR | 1 |
| Paquet, KJ | 1 |
| Conn, HO; Fessel, JM | 1 |
| Dietrich, M; Hochapfel, G; Rasche, H; Rommel, K | 1 |
| Bost, M; Franco, A; Hadjian, AJ; Pont, J | 1 |
| Navashin, SM; Zhukov, VG | 2 |
| Likoff, W | 1 |
| Fung, WP; Khoo, OT | 1 |
| Bellomo, G; Giudice, S; Tirantello, G | 1 |
| Kawamura, Y; Morito, S; Shimizu, M | 1 |
| Kienitz, M | 1 |
| Geever, EF; Levenson, SM; Nagler, AL; Seifter, E | 1 |
9 review(s) available for framycetin and Acute Disease
| Article | Year |
|---|---|
Aloe vera for treating acute and chronic wounds.
Topics: Acute Disease; Aloe; Anti-Infective Agents, Local; Bandages; Biopsy; Burns; Chronic Disease; Framycetin; Gels; Hemorrhoids; Humans; Phytotherapy; Pressure Ulcer; Randomized Controlled Trials as Topic; Silver Sulfadiazine; Skin; Time Factors; Wound Healing; Wounds and Injuries | 2012 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Acute otitis externa: an update.
Topics: Acetic Acid; Acute Disease; Anti-Bacterial Agents; Bacteria; Benzethonium; Drug Combinations; Humans; Hydrocortisone; Neomycin; Otitis Externa; Polymyxin B; Practice Guidelines as Topic; Propylene Glycols; Pseudomonas aeruginosa; Risk Factors; Staphylococcus aureus; Treatment Outcome | 2012 |
[Is the "specific" treatment of acute hepatic encephalopathy during liver cirrhosis justified?].
Topics: Acute Disease; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Mannitol; Neomycin; Therapeutic Irrigation | 1994 |
Effect of different regimens of gut decontamination on bacterial translocation and mortality in experimental acute pancreatitis.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Decontamination; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Intestines; Metronidazole; Necrosis; Neomycin; Pancreatitis; Polymyxin B; Rats; Rats, Inbred Strains; Survival Rate | 1995 |
Treatment of acute hepatic encephalopathy.
Topics: Acid-Base Imbalance; Acute Disease; Adrenal Cortex Hormones; Antacids; Anti-Bacterial Agents; Blood Coagulation Disorders; Bromocriptine; Cimetidine; Critical Care; Cross Circulation; Diuretics, Osmotic; Exchange Transfusion, Whole Blood; Extracorporeal Circulation; Gastrointestinal Hemorrhage; Hemoperfusion; Hepatic Encephalopathy; Hepatitis B Antibodies; Humans; Lactulose; Levodopa; Liver Circulation; Liver Transplantation; Neomycin; Parenteral Nutrition; Peritoneal Dialysis; Plasma; Renal Dialysis; Serum Albumin; Transplantation, Homologous | 1979 |
Hepatic coma in cirrhosis, portal hypertension, and following portacaval shunt. Its etiologies and the current status of its treatment.
Topics: Acute Disease; Amino Acids; Ammonia; Brain; Chronic Disease; Colon; Dietary Proteins; Fatty Acids; Glutamine; Hepatic Encephalopathy; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Neomycin; Neurotransmitter Agents; Portacaval Shunt, Surgical; Postoperative Complications; Sterilization; Urease | 1974 |
[The use of antibiotics in otologic practice].
Topics: Acute Disease; Anti-Bacterial Agents; Bacitracin; Bronchitis; Chloramphenicol; Chronic Disease; Ear Diseases; Humans; Labyrinth Diseases; Laryngitis; Neomycin; Novobiocin; Otitis Externa; Otitis Media; Penicillins; Pneumococcal Infections; Polymyxins; Respiratory Tract Infections; Staphylococcal Infections; Streptococcal Infections; Streptomycin; Tetracycline; Tonsillitis; Tracheal Diseases | 1969 |
Recognition and management of acute and chronic hepatic encephalopathy.
Topics: Acute Disease; Amines; Ammonia; Animals; Brain Edema; Central Nervous System; Chronic Disease; Diet Therapy; Dihydroxyphenylalanine; Exchange Transfusion, Whole Blood; Fatty Acids, Volatile; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Neomycin; Renal Dialysis | 1973 |
24 trial(s) available for framycetin and Acute Disease
| Article | Year |
|---|---|
Co-trimoxazole alone for prevention of bacterial infection in patients with acute leukaemia.
Topics: Acute Disease; Adult; Aged; Bacterial Infections; Clinical Trials as Topic; Colistin; Drug Combinations; Drug Therapy, Combination; Female; Framycetin; Humans; Leukemia; Male; Middle Aged; Neutropenia; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1982 |
Oral non-absorbed antibiotics prevent infection in acute non-lymphoblastic leukaemia.
Topics: Acute Disease; Administration, Oral; Administration, Topical; Adolescent; Adult; Antineoplastic Agents; Bacterial Infections; Bacteroides Infections; Chlorhexidine; Colistin; Drug Combinations; Enterobacteriaceae Infections; Framycetin; Humans; Leukemia; Nystatin; Remission, Spontaneous; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections | 1977 |
Fucithalmic in acute conjunctivitis. Open, randomized comparison of fusidic acid, chloramphenicol and framycetin eye drops.
Topics: Acute Disease; Adult; Chloramphenicol; Clinical Trials as Topic; Conjunctivitis, Bacterial; Drug Resistance, Microbial; Female; Framycetin; Fusidic Acid; Humans; Infant; Male; Random Allocation | 1987 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Comparison of efficacy and safety of ciprofloxacin otic solution 0.2% versus polymyxin B-neomycin-hydrocortisone in the treatment of acute diffuse otitis externa*.
Topics: Acute Disease; Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Child; Child, Preschool; Ciprofloxacin; Drug Combinations; Female; Humans; Hydrocortisone; Male; Middle Aged; Neomycin; Otitis Externa; Pharmaceutical Solutions; Polymyxin B; Spain; United States | 2008 |
Comparison of steroid antibiotic pack and 10% ichthammol glycerine pack in relieving pain of acute otitis externa in children.
Topics: Acute Disease; Betamethasone Valerate; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Follow-Up Studies; Glycerol; Humans; Infant; Male; Neomycin; Nepal; Otitis Externa; Pain Measurement; Prospective Studies; Quaternary Ammonium Compounds; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2011 |
[Ear drops otofa and polydexa for treatment of acute external otitis media in children].
Topics: Acute Disease; Administration, Topical; Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Dexamethasone; Drug Combinations; Humans; Infant; Infant, Newborn; Neomycin; Otitis Externa; Polymyxin B; Rifamycins | 2003 |
Acute otitis externa: efficacy and tolerability of N-chlorotaurine, a novel endogenous antiseptic agent.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Child; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Hydrocortisone; Male; Middle Aged; Neomycin; Otitis Media; Polymyxin B; Taurine | 2004 |
Prospective randomised single-blind controlled trial of glacial acetic acid versus glacial acetic acid, neomycin sulphate and dexamethasone spray in otitis externa and infected mastoid cavities.
Topics: Acetic Acid; Acute Disease; Administration, Topical; Aerosols; Anti-Bacterial Agents; Anti-Inflammatory Agents; Dexamethasone; Drug Therapy, Combination; Humans; Mastoiditis; Neomycin; Otitis Externa; Prospective Studies; Severity of Illness Index; Single-Blind Method | 2006 |
A randomised controlled trial comparing Triadcortyl with 10% glycerine-ichthammol in the initial treatment of severe acute otitis externa.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Drug Combinations; Female; Glycerol; Gramicidin; Humans; Male; Middle Aged; Neomycin; Nystatin; Otitis Externa; Pain Measurement; Quaternary Ammonium Compounds; Solvents; Treatment Outcome; Triamcinolone Acetonide | 2008 |
Co-trimoxazole versus non-absorbable antibiotics in acute leukaemia.
Topics: Acute Disease; Anti-Bacterial Agents; Bone Marrow Transplantation; Clinical Trials as Topic; Colistin; Drug Combinations; Humans; Infection Control; Leukemia, Myeloid; Mycoses; Neomycin; Prospective Studies; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1982 |
Prophylaxis of bacteriuria during intermittent catheterization of the acute neurogenic bladder.
Topics: Acute Disease; Bacteriuria; Drug Therapy, Combination; Humans; Male; Neomycin; Nitrofurantoin; Polymyxin B; Polymyxins; Prospective Studies; Urinary Bladder, Neurogenic; Urinary Catheterization | 1980 |
A double-blind comparison of two different treatments for acute enteritis in adults.
Topics: Acute Disease; Adult; Aged; Bacitracin; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Enteritis; Feces; Female; Humans; Male; Middle Aged; Neomycin; Streptococcus | 1981 |
Lactose enemas plus placebo tablets vs. neomycin tablets plus starch enemas in acute portal systemic encephalopathy. A double-blind randomized controlled study.
Topics: Acute Disease; Adult; Double-Blind Method; Enema; Feces; Female; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Lactose; Male; Middle Aged; Neomycin; Placebos; Random Allocation; Starch | 1981 |
[Lactulose-neomycin combination versus placebo in the treatment of acute hepatic encephalopathy. Results of a randomized controlled trial].
Topics: Acute Disease; Aged; Drug Therapy, Combination; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Neomycin; Placebos | 1994 |
Effect of different regimens of gut decontamination on bacterial translocation and mortality in experimental acute pancreatitis.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Decontamination; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Intestines; Metronidazole; Necrosis; Neomycin; Pancreatitis; Polymyxin B; Rats; Rats, Inbred Strains; Survival Rate | 1995 |
[Double-blind study of the bacitracin-neomycin combination in the treatment of acute bacterial enteritis].
Topics: Acute Disease; Adult; Aged; Bacitracin; Bacterial Infections; Drug Combinations; Drug Evaluation; Enteritis; Female; Humans; Male; Middle Aged; Neomycin | 1978 |
Prevention of infection in patients with acute nonlymphocytic leukemia by several drug treatment regimens.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Clinical Trials as Topic; Colistin; Drug Combinations; Drug Therapy, Combination; Humans; Infection Control; Leukemia; Neomycin; Neutropenia; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Some aspects in the diagnosis and management of external infections of the eye: experiences with a new antibiotic, gentamicin.
Topics: Acute Disease; Bacitracin; Bacteria; Bacteriological Techniques; Clinical Trials as Topic; Eye Diseases; Female; Gentamicins; Humans; Infections; Male; Neomycin; Polymyxins; Staphylococcal Infections; Staphylococcus; Tyrothricin | 1970 |
[The physiopathology of inflammatory nasal mucosa lesions. The significance of the galenic type of local therapeutic agents].
Topics: Acute Disease; Adolescent; Adult; Aged; Child; Child, Preschool; Cilia; Evaluation Studies as Topic; Female; Gels; Histamine H1 Antagonists; Humans; Male; Methylcellulose; Middle Aged; Mucus; Nasal Mucosa; Neomycin; Pharmaceutical Vehicles; Phenylephrine; Rhinitis; Rhinitis, Allergic, Seasonal | 1970 |
The place of antibiotics in the treatment of acute gastroenteritis in general practice: a controlled clinical trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Child; Child, Preschool; Clinical Trials as Topic; Diarrhea; Family Practice; Gastroenteritis; Humans; Infant; Kaolin; Middle Aged; Neomycin | 1973 |
Antimicrobial therapy as a part of the decontamination procedures for patients with acute leukemia.
Topics: Acute Disease; Anti-Bacterial Agents; Bacitracin; Blood Cell Count; Blood Platelets; Disinfection; Drug Combinations; Fever; Germ-Free Life; Glucose; Hexetidine; Humans; Leukemia; Neomycin; Neutropenia; Nystatin; Patient Isolators; Pneumonia; Remission, Spontaneous; Respiratory Tract Infections; Sterilization; Thrombelastography; Time Factors; Xylose | 1973 |
[Treatment of infantile acute diarrheas by neomycin].
Topics: Acute Disease; Clinical Trials as Topic; Diarrhea, Infantile; Humans; Infant; Infant, Newborn; Neomycin | 1969 |
Local treatment with a corticosteroid-antibiotic preparation in infections of the ear.
Topics: Acute Disease; Adolescent; Adult; Aged; Child; Child, Preschool; Chronic Disease; Clinical Trials as Topic; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Neomycin; Otitis Media; Placebos; Triamcinolone Acetonide | 1970 |
48 other study(ies) available for framycetin and Acute Disease
| Article | Year |
|---|---|
Acute haemorrhagic keratoconjunctivitis following laser in situ keratomileusis.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Cornea; Eye Hemorrhage; Framycetin; Humans; Keratoconjunctivitis; Keratomileusis, Laser In Situ; Male; Myopia | 2000 |
Antibiotic prophylaxis for patients in protective isolation.
Topics: Acute Disease; Bacterial Infections; Colistin; Drug Evaluation; Drug Therapy, Combination; Framycetin; Humans; Leukemia; Neomycin; Nystatin; Patient Isolation | 1979 |
Prophylaxis against septicaemia in acute leukaemia: the use of oral framycetin.
Topics: Acute Disease; Administration, Oral; Adult; Escherichia coli Infections; Female; Fever; Framycetin; Humans; Leukemia; Leukocyte Count; Male; Neutrophils; Pseudomonas aeruginosa; Pseudomonas Infections; Remission, Spontaneous; Sepsis; Staphylococcal Infections | 1973 |
[Clinical trial of topifram].
Topics: Acute Disease; Administration, Topical; Adolescent; Adult; Aged; Anti-Infective Agents, Local; Anti-Inflammatory Agents; Child; Drug Combinations; Drug Tolerance; Eczema; Female; Framycetin; Glucocorticoids; Humans; Infant; Keratosis; Lichen Planus; Male; Middle Aged; Pityriasis; Prurigo; Psoriasis; Rosacea; Skin Diseases, Infectious; Tyrothricin | 1972 |
Epidemic acute conjunctivitis.
Topics: Acute Disease; Aged; Child; Chloramphenicol; Conjunctivitis; Disease Outbreaks; Framycetin; Humans; India; Ophthalmic Solutions; Sodium Chloride; Sulfaphenazole | 1972 |
Gut Microbiota-Derived Diaminopimelic Acid Promotes the NOD1/RIP2 Signaling Pathway and Plays a Key Role in the Progression of Severe Acute Pancreatitis.
Topics: Acute Disease; Animals; Diaminopimelic Acid; Gastrointestinal Microbiome; Neomycin; NF-kappa B; Nod1 Signaling Adaptor Protein; Pancreatitis; Rats; Signal Transduction | 2022 |
Differences in bacteriologic treatment failures in acute otitis externa between ciprofloxacin/dexamethasone and neomycin/polymyxin B/hydrocortisone: results of a combined analysis.
Topics: Acute Disease; Administration, Topical; Ciprofloxacin; Dexamethasone; Drug Therapy, Combination; Humans; Hydrocortisone; Neomycin; Otitis Externa; Polymyxin B; Pseudomonas aeruginosa; Staphylococcus aureus | 2009 |
[Nebacetin therapy of acute maxillary sinusitis].
Topics: Acute Disease; Bacitracin; Disease; Maxillary Sinus; Maxillary Sinusitis; Neomycin; Paranasal Sinus Diseases; Sinusitis | 1957 |
[CONTRIBUTION TO THE CLINICAL ASPECTS OF APPENDICITIS].
Topics: Acute Disease; Appendectomy; Appendicitis; Bacitracin; Biometry; Humans; Neomycin; Peritonitis; Statistics as Topic | 1963 |
Optical stimulation of auditory neurons: effects of acute and chronic deafening.
Topics: Acute Disease; Animals; Chronic Disease; Cochlear Nerve; Deafness; Electric Stimulation; Evoked Potentials, Auditory, Brain Stem; Gerbillinae; Light; Models, Animal; Neomycin; Nerve Degeneration; Protein Synthesis Inhibitors; Spiral Ganglion | 2008 |
An epidemic of acute conjunctivitis caused by enterovirus-70 in Singapore in 1980.
Topics: Acute Disease; Adolescent; Adult; Child; Child, Preschool; Conjunctivitis; Disease Outbreaks; Enterovirus; Enterovirus Infections; Female; Humans; Male; Neomycin; Singapore | 1981 |
[Acute liver failure--therapeutic aspects 1982].
Topics: Acute Disease; Animals; Antithrombins; Blood Coagulation Factors; Cimetidine; Dietary Carbohydrates; Enema; Exchange Transfusion, Whole Blood; Gastrointestinal Hemorrhage; Glucose; Humans; Lactulose; Liver Diseases; Neomycin; Papio; Paromomycin; Peptic Ulcer; Plasma Exchange | 1982 |
[Glucose solution to improve the treatment results in acute bovine mastitis].
Topics: Acute Disease; Animals; Cattle; Female; Glucose; Infusions, Parenteral; Mastitis, Bovine; Neomycin; Penicillins | 1981 |
Oxindole, a sedative tryptophan metabolite, accumulates in blood and brain of rats with acute hepatic failure.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Brain; Galactosamine; Hypnotics and Sedatives; Indoles; Liver Failure; Male; Neomycin; Oxindoles; Rats; Rats, Wistar; Thioacetamide; Tryptophan | 1998 |
[Selective intestinal bacterial decontamination in experimental acute pancreatitis].
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Bacitracin; Bacterial Translocation; Cholagogues and Choleretics; Disinfection; Escherichia coli; Gentamicins; Intestines; Neomycin; Pancreatitis; Rats; Rats, Sprague-Dawley; Taurodeoxycholic Acid | 2000 |
[Treatment of acute alcoholic hepatitis].
Topics: Acute Disease; Adrenal Cortex Hormones; Anabolic Agents; Colchicine; Hepatitis, Alcoholic; Humans; Levodopa; Neomycin; Parenteral Nutrition | 1979 |
[Study of the antibiotic sensitivity of the Shigellae, pathogenic Escherichia, Proteus and Staphylococcus isolated from young children in Tbilisi with acute intestinal diseases].
Topics: Acute Disease; Anti-Bacterial Agents; Child; Chloramphenicol; Chlortetracycline; Drug Resistance, Microbial; Escherichia; Georgia (Republic); Humans; Intestinal Diseases; Microbial Sensitivity Tests; Neomycin; Oxytetracycline; Proteus; Shigella; Species Specificity; Staphylococcus; Streptomycin; Tetracycline | 1975 |
Treatment of fulminant viral hepatitis with anti-lymphocyte gamma globulins.
Topics: Acute Disease; Adolescent; Adult; Antibody Formation; Antilymphocyte Serum; Child; Dexamethasone; Female; Glucose; Hepatitis, Viral, Human; Humans; Lactulose; Male; Middle Aged; Neomycin; Peritoneal Dialysis; Rosette Formation | 1979 |
[Use of neomycin in the treatment of acute hepatoportal encephalopathy].
Topics: Acute Disease; Adult; Female; Hepatic Encephalopathy; Humans; Male; Neomycin | 1976 |
Acute hepatic failure.
Topics: Acute Disease; Exchange Transfusion, Whole Blood; Hepatic Encephalopathy; Hepatitis A; Humans; Lactulose; Neomycin | 1975 |
[Letter: Acute iatrogenic colitis following clindamycin and various antibiotics].
Topics: Acute Disease; Anti-Bacterial Agents; Bone Diseases; Clindamycin; Colistin; Colitis; Drug Combinations; Drug Hypersensitivity; Humans; Neomycin; Sulfamethoxazole; Trimethoprim | 1975 |
Preventing perioperative obstruction of tympanostomy tubes: a prospective trial of a simple method.
Topics: Acute Disease; Adolescent; Anti-Infective Agents, Local; Bacitracin; Blood; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ear Diseases; Equipment Failure; Eustachian Tube; Hemorrhage; Humans; Infant; Intraoperative Complications; Middle Ear Ventilation; Neomycin; Otitis Media; Otitis Media with Effusion; Polymyxin B; Prospective Studies | 1991 |
Selective decontamination of the digestive tract for the prevention of infection in acute leukemia.
Topics: Acute Disease; Amphotericin B; Bacterial Infections; Digestive System; Drug Combinations; Humans; Leukemia; Leukocyte Count; Neomycin; Polymyxin B; Polymyxins; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
Acute ammonia intoxication 37 years after ureterosigmoidostomy.
Topics: Acute Disease; Adult; Ammonia; Colon, Sigmoid; Hepatic Encephalopathy; Humans; Magnetic Resonance Imaging; Male; Neomycin; Time Factors; Urea; Ureterostomy | 1988 |
Microbiological monitoring of patients in hepatic failure with particular reference to extracorporeal porcine liver perfusion.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Ampicillin; Animals; Candida; Clostridium perfringens; Cloxacillin; Electroencephalography; Enterobacteriaceae; Enterococcus faecalis; Escherichia coli; Feces; Female; Hepatic Encephalopathy; Humans; Inguinal Canal; Klebsiella; Liver; Male; Middle Aged; Neisseria meningitidis; Neomycin; Nose; Perfusion; Pharynx; Proteus; Pseudomonas aeruginosa; Sepsis; Skin; Staphylococcus; Swine | 1971 |
[Use of kenakort and kenacomb in the therapy of certain dermatoses].
Topics: Acute Disease; Adolescent; Adult; Aged; Chronic Disease; Drug Combinations; Female; Gramicidin; Humans; Hypersensitivity; Male; Middle Aged; Neomycin; Nystatin; Ointments; Skin Diseases; Triamcinolone Acetonide | 1974 |
[Use of foam preparations in pressurized containers in the treatment of mastitis].
Topics: Acute Disease; Animals; Cattle; Dairying; Female; Neomycin; Oxytetracycline; Skin Absorption; Streptomycin | 1973 |
[Use of propaxoline citrate, iodochloroxyquinoline and neomycin (Enterum) in pediatric practice].
Topics: Acute Disease; Child, Preschool; Clioquinol; Diarrhea; Drug Combinations; Dyspepsia; Female; Gastrointestinal Diseases; Humans; Infant; Male; Neomycin; Oxazoles; Respiratory Tract Infections; Spasm | 1972 |
The Fairley test: an aid in the diagnosis of pyelonephritis in paraplegia.
Topics: Acute Disease; Adolescent; Adult; Aged; Bacteriological Techniques; Bacteriuria; Deoxyribonucleases; Diuresis; Fibrinolysin; Furosemide; Humans; Kidney; Middle Aged; Neomycin; Paraplegia; Pyelonephritis; Sodium Chloride; Therapeutic Irrigation; Urinary Bladder; Urinary Catheterization | 1974 |
Gastrointestinal "sterilization" in the treatment of patients with acute leukemia.
Topics: Acute Disease; Agranulocytosis; Anti-Bacterial Agents; Antineoplastic Agents; Bacitracin; Bacteriological Techniques; Diet Therapy; Dietetics; Digestive System; Drug Synergism; Feces; Gastroenteritis; Gentamicins; Humans; Infection Control; Infections; Leukemia; Leukocyte Count; Neomycin; Nystatin; Polymyxins; Sterilization | 1970 |
[Characteristic of the causative agents of acute pneumonia isolated from patients treated with antibiotics].
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Bacteria; Chloramphenicol; Chlortetracycline; Depression, Chemical; Enterococcus faecalis; Erythromycin; Erythromycin Ethylsuccinate; Female; Furazolidone; Humans; Male; Middle Aged; Neomycin; Nitrofurantoin; Oleandomycin; Oxytetracycline; Penicillin G; Penicillin Resistance; Penicillins; Pneumonia; Polymyxins; Ristocetin; Staphylococcus; Streptococcus; Streptomycin; Tetracycline; Urine | 1970 |
The prevention of infection in appendicectomy wounds.
Topics: Acute Disease; Appendectomy; Appendicitis; Appendix; Bacitracin; Humans; Methods; Neomycin; Penicillins; Polymyxins; Streptomycin; Surgical Wound Infection; Tetracycline | 1971 |
[Sex chromatin in neutrophilic leukocytes in the blood of children treated with antibiotics].
Topics: Acute Disease; Adenoviridae Infections; Anti-Bacterial Agents; Child; Child, Preschool; Chloramphenicol; Dysentery, Bacillary; Encephalitis; Enteritis; Erythromycin Ethylsuccinate; Escherichia coli Infections; Female; Humans; Infant; Infections; Male; Neomycin; Neutrophils; Penicillins; Pneumonia; Polymyxins; Sex Chromatin; Streptomycin | 1971 |
[Sensitivity of the microbial flora isolated from ill young children with acute gastrointestinal diseases to antibiotics, chemical preparations and polyvalent proteus phage].
Topics: Acute Disease; Ampicillin; Anti-Bacterial Agents; Child; Child, Preschool; Chloramphenicol; Clioquinol; Enterococcus faecalis; Erythromycin; Erythromycin Ethylsuccinate; Escherichia coli; Feces; Furazolidone; Gastroenteritis; Humans; Methicillin; Nalidixic Acid; Neomycin; Oleandomycin; Oxytetracycline; Penicillin G; Phenanthrenes; Polymyxins; Proteus; Staphylococcus; Streptomycin; Tetracycline; Tetracyclines | 1974 |
Clinical trials with a new dermatologic solution.
Topics: Acute Disease; Animals; Anti-Infective Agents, Local; Chronic Disease; Dermatologic Agents; Dexamethasone; Dog Diseases; Dogs; Drug Combinations; Evaluation Studies as Topic; Female; Male; Neomycin; Otitis Externa; Pseudomonas Infections; Skin Diseases, Infectious; Thiabendazole | 1972 |
[Types and frequency of R-factor carriage in intestinal bacilli isolated from patients with acute dysentery].
Topics: Acute Disease; Chloramphenicol; Conjugation, Genetic; Dysentery, Bacillary; Erythromycin Ethylsuccinate; Escherichia coli; Genetics, Microbial; Humans; Microbial Sensitivity Tests; Neomycin; Shigella flexneri; Streptomycin; Tetracycline | 1972 |
Microbial flora of stomach and small intestine in infantile gastroenteritis.
Topics: Acute Disease; Candida albicans; Duodenum; Escherichia coli; Feces; Female; Gastroenteritis; Humans; Infant; Intestine, Small; Male; Mouth; Neomycin; Penicillins; Salmonella typhimurium; Stomach | 1974 |
[Clinical aspects and therapy of acute and chronic liver insufficiency and hepatic failure].
Topics: Acid-Base Equilibrium; Acute Disease; Animals; Blood Donors; Chronic Disease; Diet Therapy; Exchange Transfusion, Whole Blood; Haplorhini; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Intestines; Liver Transplantation; Neomycin; Papio; Swine | 1972 |
Lactulose in the treatment of acute hepatic encephalopathy.
Topics: Acute Disease; Ammonia; Connecticut; Dietary Proteins; Evaluation Studies as Topic; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Neomycin; Nitrogen | 1973 |
[Comparative experimental study of ceporin and oxacillin].
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Cephaloridine; Cephalothin; Depression, Chemical; Erythromycin; Erythromycin Ethylsuccinate; Fusidic Acid; Lincomycin; Mice; Microbial Sensitivity Tests; Neomycin; Novobiocin; Oxacillin; Penicillin G; Penicillin Resistance; Staphylococcal Infections; Staphylococcus; Tetracycline | 1970 |
[Comparative experimental study of ceporin and ampicillin].
Topics: Acute Disease; Ampicillin; Animals; Cephaloridine; Cephalothin; Depression, Chemical; Erythromycin Ethylsuccinate; Escherichia coli; Escherichia coli Infections; Mice; Microbial Sensitivity Tests; Neomycin; Penicillin Resistance; Proteus; Proteus Infections; Streptomycin; Tetracycline | 1970 |
[Blood cholesterol content in children following administration of monomycin and neomycin by various routes].
Topics: Acute Disease; Anti-Bacterial Agents; Child; Child, Preschool; Chloramphenicol; Cholesterol; Depression, Chemical; Dysentery, Bacillary; Erythromycin Ethylsuccinate; Humans; Infant; Injections, Intramuscular; Neomycin; Streptomycin; Time Factors | 1970 |
Symposium on arteriosclerotic heart disease. Medical management of angina pectoris.
Topics: Acute Disease; Angina Pectoris; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Diet Therapy; Exercise Therapy; Heparin; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension; Neomycin; Nicotinic Acids; Nitrates; Stress, Physiological; Thyroxine; Triglycerides | 1972 |
Lactulose in the treatment of acute and chronic hepatic encephalopathy.
Topics: Acute Disease; Aged; Brain Diseases; Chronic Disease; Disaccharides; Fructose; Humans; Liver Diseases; Male; Middle Aged; Neomycin | 1971 |
[Controlled quantitative evaluation of the efficiency of some antibiotics in the treatment of acute enteritis in children].
Topics: Acetates; Acute Disease; Anti-Bacterial Agents; Child; Child, Preschool; Chloramphenicol; Enteritis; Humans; Infant; Neomycin | 1969 |
[Experience in using the 2 levels of concentration of Betnevate N cream (betamethasone 17-valerate with Fradiomycin sulfate)].
Topics: Acute Disease; Adult; Aged; Betamethasone; Child; Child, Preschool; Dermatitis, Atopic; Dermatitis, Contact; Eczema; Female; Humans; Infant; Male; Middle Aged; Neomycin; Pregnanetriol; Psoriasis; Skin Diseases; Valerates | 1970 |
[On the antibiotic treatment of acute enteritis in children].
Topics: Acute Disease; Candida; Child; Child, Preschool; Enteritis; Feces; Humans; Infant; Infant, Newborn; Kaolin; Mouth; Neomycin; Pectins | 1967 |
Acute choline deficiency in germfree, conventionalized and open-animal-room rats: effects of neomycin, chlortetracycline, vitamin B12 and coprophagy prevention.
Topics: Acute Disease; Animals; Blood Urea Nitrogen; Body Weight; Chlortetracycline; Cholesterol; Choline Deficiency; Cystine; Diet; Feces; Germ-Free Life; Hematocrit; Kidney Diseases; Lipid Metabolism; Liver; Male; Neomycin; Rats; Stimulation, Chemical; Vitamin B 12 | 1968 |